Keywords: NF1، نوروفیبروماتوز نوع 1; AP, auditory processing; ATPD, auditory temporal processing deficits; CNS, central nervous system; DP, Duration Patterns; FP, Frequency Patterns; GIN, Gaps in Noise; HL, hearing level; NF1, neurofibromatosis type 1; NHI, National Institutes of Health; SNV
مقالات ISI NF1، نوروفیبروماتوز نوع 1 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: NF1، نوروفیبروماتوز نوع 1; ERK, extracellular signal-regulated kinase; GTP, guanosine triphosphate; MAPK, mitogen-activated protein kinase; NF1, neurofibromatosis type 1; WT, wild type
Oncolytic measles virus as a novel therapy for malignant peripheral nerve sheath tumors
Keywords: NF1، نوروفیبروماتوز نوع 1; MPNST, malignant peripheral nerve sheath tumors; MV, measles virus; MVEdm, MV Edmonston vaccine strain; NIS, human sodium iodide symporter; CPE, cytopathic effect; I-125, iodine-125; NF1, neurofibromatosis type 1; DMEM, Dulbecco's modified Eagle's medium;
High-resolution 400K oligonucleotide array comparative genomic hybridization analysis of neurofibromatosis type 1-associated cutaneous neurofibromas
Keywords: NF1، نوروفیبروماتوز نوع 1; NF1, neurofibromatosis type 1; RT-PCR, reverse transcription polymerase chain reaction; BAC, bacterial artificial chromosome; CGH, comparative genomic hybridization; pNFs, plexiform neurofibromas; MPNST, malignant peripheral nerve sheath tumors; aCGH, arr
Development of an international internet-based neurofibromatosis Type 1 Patient registry
Keywords: NF1، نوروفیبروماتوز نوع 1; NF1, neurofibromatosis type 1; MPNST, malignant peripheral nerve sheath tumor; NPRI, NF1 Patient Registry InitiativeNeurofibromatosis type 1; Rare disease; Genetic syndrome; Registry; Internet; Online
Nevus anemicus in neurofibromatosis type 1: A potential new diagnostic criterion
Keywords: NF1، نوروفیبروماتوز نوع 1; café-au-lait macules; Legius syndrome; neurofibromatosis type 1; nevus anemicusCALM, café-au-lait macule; JXG, juvenile xanthogranuloma; NA, nevus anemicus; NF1, neurofibromatosis type 1; NIH, National Institutes of Health; OG, optic glioma; PN, plexiform
Decreased bone mineralization in children with Noonan syndrome: Another consequence of dysregulated RAS MAPKinase pathway?
Keywords: NF1، نوروفیبروماتوز نوع 1; NS, Noonan syndrome; NF1, Neurofibromatosis type 1; BMD, Bone mineral density; BMC, Bone mineral content; DXA, Dual-energy X-ray absorptiometry; IRB, Institutional Review BoardNoonan syndrome; Bone mineral density; RAS-MAPK pathway; DXA
Osteoclasts derived from patients with neurofibromatosis 1 (NF1) display insensitivity to bisphosphonates in vitro
Keywords: NF1، نوروفیبروماتوز نوع 1; NF1, neurofibromatosis type 1; BMD, bone mineral density; CTX, collagen type I C-terminal telopeptide; PINP, procollagen type I N-terminal propeptide; TRACP5b, tartrate resistant acid phosphatase 5b; MCSF, macrophage colony stimulating factor; RANKL, rece
Growth Hormone Excess in Children with Neurofibromatosis Type 1-Associated and Sporadic Optic Pathway Tumors
Keywords: NF1، نوروفیبروماتوز نوع 1; GH, Growth hormone; GHRH, Growth hormone-releasing hormone; IGF-1, Insulin-like growth factor 1; IGFBP-3, Insulin-like growth factor binding protein 3; LH, Luteinizing hormone; NF1, Neurofibromatosis Type 1; OPT, Optic pathway tumor
Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model
Keywords: NF1، نوروفیبروماتوز نوع 1; NF1, Neurofibromatosis type 1; PDEXA, Peripheral dual-energy X-ray absorptiometry; BMD, Bone mineral density; pQCT, Peripheral quantitative computed tomography; ROI, Region of interest; vBMD, Volumetric bone mineral density; L, Lumbar; CFU-OBL, Colony for
Phenotypic variability among café-au-lait macules in neurofibromatosis type 1
Keywords: NF1، نوروفیبروماتوز نوع 1; café-au-lait macule; neurofibromatosis type 1; phenotype-genotype correlation; reflectance spectroscopyCALM, café-au-lait macule; CIE, Commission International d'Eclairage; NF1, neurofibromatosis type 1; NIH, National Institutes of Health
Neurofibromatosis type 1
Keywords: NF1، نوروفیبروماتوز نوع 1; BRM, blue-red macule; CALM, café-au-lait macule; FCALS, familial café-au-lait spots; JMML, juvenile myelomonocytic leukemia; JXG, juvenile xanthogranuloma; MRI, magnetic resonance imaging; NF1, neurofibromatosis type 1; NIH, National Institutes of Health;
Bone Mineral Density in Children and Adolescents with Neurofibromatosis Type 1
Keywords: NF1، نوروفیبروماتوز نوع 1; ABMD, Areal bone mineral density; BA, Bone area; BMAD, Bone mineral apparent density; BMC, Bone mineral content; BMD, Bone mineral density; DXA, Dual energy x-ray absorptiometry; MET, Metabolic cost; NF1, Neurofibromatosis type 1
Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1
Keywords: NF1، نوروفیبروماتوز نوع 1; CBCL, Child Behavior Checklist; FRI, Family Relationship Index; NF1, Neurofibromatosis type 1; QoL, Quality of life; TACQOL, TNO-AZL, Questionnaire for Children’s Health-Related Quality of Life
Lack of Evidence for an Association Between Neurofibromatosis and Pulmonary Fibrosis
Keywords: NF1، نوروفیبروماتوز نوع 1; genetics; interstitial lung disease; pulmonary fibrosisHRCT, high-resolution CT; NF, neurofibromatosis; NF1, neurofibromatosis type 1; NF2, neurofribromatosis type 2